Edison, New Jersey
United States
20
2026-06-04
The entities that hold a legal rights for patent applications filed by inventor Struthers Mary:
Mary Struthers from Edison, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
#2 | 2026-02-12Modified IgG1 Fc Domains and Anti-CD40 Domain Antibody Fusions Therewith
#3 | 2025-06-05INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METHODS OF USE
#4 | 2024-10-03FUSION PROTEINS FOR THE TREATMENT OF DISEASE
#5 | 2024-07-18Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
#6 | 2024-04-18Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
#7 | 2023-10-19Method of Treating an Autoimmune Disease with Antagonistic CD40 Monoclonal Antibodies
#8 | 2023-10-12Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
#9 | 2022-11-03Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use
#10 | 2022-06-09Nucleic acids encoding antagonistic CD40 monoclonal antibodies
#11 | 2022-06-02Antagonistic CD40 monoclonal antibodies and uses thereof
#12 | 2022-05-19Antagonistic CD40 monoclonal antibodies and uses thereof
#13 | 2022-05-12Antagonistic CD40 monoclonal antibodies and uses thereof
#14 | 2021-02-25Antagonistic CD40 monoclonal antibodies and uses in treating immune responses
#15 | 2020-05-21Antagonistic CD40 monoclonal antibodies and uses thereof
#16 | 2020-05-14MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THEREWITH
#17 | 2019-11-28Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use
#18 | 2019-10-03Interleukin-2/Interleukin-2 receptor alpha fusion proteins and methods of use
#19 | 2018-11-29Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activity
#20 | 2006-02-09Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
2358693 ⎘